Browsing by Author "Bertomeu-Martínez, Vicente"
Now showing items 1-13 of 13
-
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry
Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Raña-Míguez, Paula; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory; Marín, Francisco (NLM, 2019-12-24)[Abstract] Background. Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ... -
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study
Moreno-Arribas, José; Bertomeu-González, Vicente; Anguita, Manuel; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (SAGE, 2015-07-30)[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ... -
Diferencias en las características y el tratamiento de los pacientes con fibrilación auricular seguidos por cardiólogos y por otros especialistas
Carnero Montoro, Lucía; Roldán Rabadán, Inmaculada; Marín Ortuño, Francisco; Bertomeu-Martínez, Vicente; Muñiz, Javier; Anguita, Manuel (Elsevier, 2016-12-20) -
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation: the FANTASIIA study
Anguita-Sánchez, Manuel; Bertomeu-Martínez, Vicente; Ruiz-Ortiz, Martín; Cequier, Ángel; Roldán-Rabadán, Inmaculada; Muñiz, Javier; Badimón, Lina; Esteve-Pastor, María Asunción; Marín Ortuño, Francisco (Elsevier, 2019-05-31)[Abstract] Introduction and objectives: To compare the long-term results of direct oral anticoagulants (DOAC) vs vitamin K antagonists (VKA) in real-world-patients with nonvalvular atrial fibrillation (NVAF) in a nationwide, ... -
Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores
Esteve-Pastor, María Asunción; Marín, Francisco; Bertomeu-Martínez, Vicente; Roldán, Inmaculada; Cequier, Ángel; Badimón, Lina; Muñiz, Javier; Valdés, Mariano; Anguita, Manuel (Wiley, 2016-03-01)[Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF). AIM: The aim of this study is to assess concordance ... -
Impact of integrated care management on clinical outcomes in atrial fibrillation patients: a report from the FANTASIIA Registry
Esteve-Pastor, María Asunción; Ruiz-Ortiz, Martín; Muñiz, Javier; Roldán Rabadán, Inmaculada; Otero García, Deborah; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y. H.; Marín, Francisco (Frontiers, 2022-05)[Abstract] Background: An integrated and holistic approach is increasingly advocated in patients with atrial fibrillation (AF), based on the “Atrial fibrillation Better Care (ABC) pathway: A, Avoid stroke with anticoagulation; ... -
In-hospital mortality due to acute myocardial infarction: relevance of type of hospital and care provided: RECALCAR study
Bertomeu-Martínez, Vicente; Cequier, Ángel; Bernal, José Luis; Alfonso, Fernando; Anguita, Manuel; Muñiz, Javier; Barrabés, José A.; García-Dorado, David; Goicolea, Javier; Elola, Francisco J. (Elsevier, 2013-09-14)[Abstract] Introduction and objectives. To investigate the relationship between in-hospital mortality due to acute myocardial infarction and type of hospital, discharge service, and treatment provided. Methods. Retrospective ... -
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Ruiz Ortiz, Martín; Marín, Francisco; Roldán, Vanessa; Quesada, María Angustias; Camacho Siles, José; Cequier Fillat, Angel; Bertomeu-Martínez, Vicente; Martínez-Sellés, Manuel; Badimón, Lina (Elsevier, 2020-04-14)[Abstract] Background: While many risk factors for Atrial Fibrillation (AF) have been identified, there are important differences in their relative impact between sexes. The aim of our study was to investigate the influence ... -
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán-Rabadán, Inmaculada; Muñiz, Javier; Otero García, Deborah; Ruiz-Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Wiley, 2020-10-16)[Abstract] Background: Atrial fibrillation (AF) and peripheral artery disease (PAD) are common conditions that increase cardiovascular risk. We determined the association between PAD and prognosis in a cohort of real-world ... -
Predictive value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre spanish observational registry FANTASIIA
Marín, Francisco; Roldán, Vanessa; Bertomeu-González, Vicente; Cequier, Ángel; Muñiz, Javier; Roldán, Inmaculada; Bertomeu-Martínez, Vicente; Badimón, Lina; Lip, Gregory; Anguita, Manuel (Oxford, 2015) -
Quality of anticoagulation with vitamin K antagonists
Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ... -
Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, Marco; Esteve-Pastor, María Asunción; Rivera-Caravaca, José Miguel; Roldán, Vanessa; Roldán Rabadán, Inmaculada; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Elsevier, 2021-07-23)[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ... -
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...
